4l8i: Difference between revisions
From Proteopedia
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
==Crystal structure of RSV epitope scaffold FFL_005== | |||
=== | <StructureSection load='4l8i' size='340' side='right' caption='[[4l8i]], [[Resolution|resolution]] 2.00Å' scene=''> | ||
== Structural highlights == | |||
<table><tr><td colspan='2'>[[4l8i]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/Synthetic_construct_sequences Synthetic construct sequences]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4L8I OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4L8I FirstGlance]. <br> | |||
</td></tr><tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4l8i FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4l8i OCA], [http://www.rcsb.org/pdb/explore.do?structureId=4l8i RCSB], [http://www.ebi.ac.uk/pdbsum/4l8i PDBsum]</span></td></tr> | |||
</table> | |||
<div style="background-color:#fffaf0;"> | |||
== Publication Abstract from PubMed == | |||
Vaccines prevent infectious disease largely by inducing protective neutralizing antibodies against vulnerable epitopes. Several major pathogens have resisted traditional vaccine development, although vulnerable epitopes targeted by neutralizing antibodies have been identified for several such cases. Hence, new vaccine design methods to induce epitope-specific neutralizing antibodies are needed. Here we show, with a neutralization epitope from respiratory syncytial virus, that computational protein design can generate small, thermally and conformationally stable protein scaffolds that accurately mimic the viral epitope structure and induce potent neutralizing antibodies. These scaffolds represent promising leads for the research and development of a human respiratory syncytial virus vaccine needed to protect infants, young children and the elderly. More generally, the results provide proof of principle for epitope-focused and scaffold-based vaccine design, and encourage the evaluation and further development of these strategies for a variety of other vaccine targets, including antigenically highly variable pathogens such as human immunodeficiency virus and influenza. | |||
Proof of principle for epitope-focused vaccine design.,Correia BE, Bates JT, Loomis RJ, Baneyx G, Carrico C, Jardine JG, Rupert P, Correnti C, Kalyuzhniy O, Vittal V, Connell MJ, Stevens E, Schroeter A, Chen M, Macpherson S, Serra AM, Adachi Y, Holmes MA, Li Y, Klevit RE, Graham BS, Wyatt RT, Baker D, Strong RK, Crowe JE, Johnson PR, Schief WR Nature. 2014 Feb 5. doi: 10.1038/nature12966. PMID:24499818<ref>PMID:24499818</ref> | |||
== | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | ||
</div> | |||
[[Category: Correnti, C | == References == | ||
[[Category: Holmes, M A | <references/> | ||
[[Category: Jardine, J | __TOC__ | ||
[[Category: Schief, W R | </StructureSection> | ||
[[Category: Strong, R K | [[Category: Synthetic construct sequences]] | ||
[[Category: Correnti, C]] | |||
[[Category: Holmes, M A]] | |||
[[Category: Jardine, J]] | |||
[[Category: Schief, W R]] | |||
[[Category: Strong, R K]] | |||
[[Category: Immune system]] | [[Category: Immune system]] | ||
[[Category: Three-helix bundle]] | [[Category: Three-helix bundle]] | ||
